Visualizar por autor "Ayesa Arriola, Rosa"

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis

Vázquez Bourgon, Javier

; Mata Pastor, Ignacio; Roiz Santiáñez, Roberto Miguel; Ayesa Arriola, Rosa

; Suárez Pinilla, Paula

; Tordesillas Gutiérrez, Diana

; Vázquez Barquero, José Luis

; Crespo Facorro, Benedicto

(Korean Neuropsychiatric Association, 2014)

A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype

Murillo García, Nancy; Díaz-Pons, Alexandre; Fernández Cacho, Luis Manuel

; Miguel-Corredera, Margarita; Martínez del Barrio, María Elena; Ortiz-García de la Foz, Víctor; Neergaard, Karl; Ayesa Arriola, Rosa

(John Wiley & Sons, 2022)

Análisis de la velocidad de procesamiento en Primeros Episodios Psicóticos

Fernández García, Xacobe Abel (2017-09)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone

Gómez Revuelta, Marcos; Pelayo Terán, José María; Juncal Ruiz, María; Vázquez Bourgon, Javier

; Suárez Pinilla, Paula

; Romero Jiménez, Rodrigo; Setién Suero, María Esther; Ayesa Arriola, Rosa

; Crespo Facorro, Benedicto

(Oxford University Press, 2020-01-24)

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial

Garrido-Sánchez, Lucía; Gómez-Revuelta, Marcos; Ortiz-García de la Foz, Víctor; Pelayo-Terán, José María; Juncal-Ruiz, María; Ruiz-Veguilla, Miguel; Mayoral-Van Son, Jacqueline; Ayesa Arriola, Rosa

; Vázquez Bourgon, Javier

; Crespo Facorro, Benedicto

(Oxford University Press, 2022)

Biomarkers as proxies for cognitive reserve: the role of high density lipoprotein cholesterol in first episode of psychosis

Magdaleno Herrero, Rebeca; Murillo García, Nancy; Yorca Ruiz, Ángel; Neergaard, Karl; Crespo Facorro, Benedicto

; Ayesa Arriola, Rosa

(Elsevier España S.L.U., 2024)

Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients

Vázquez Bourgon, Javier

; Ortiz-García de la Foz, Víctor; Suarez Pereira, Irene; Iruzubieta, Paula; Arias Loste, María Teresa

; Setién Suero, María Esther; Ayesa Arriola, Rosa

; Gómez Revuelta, Marcos; Crespo García, Javier

; Crespo Facorro, Benedicto

(Elsevier, 2019-12)

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences

Setién Suero, María Esther; Neergaard, Karl; Ramírez Bonilla, María Luz; Correa Ghisays, Patricia; Fañanás, Lourdes; Crespo Facorro, Benedicto

; Ayesa Arriola, Rosa

(Public Library of Science, 2017-08)

Carga alostática en pacientes con un primer episodio psicótico: estudio longitudinal a 1, 3 y 10 años de seguimiento

Beruete Fresnillo, Itziar (2022-06-27)

Childhood early life adverse events and neurocognitive deficits in first episode psychosis patients

Echave Guillén, Ariana (2016-07-11)

Childhood trauma and substance use underlying psychosis: a systematic review

Setién Suero, María Esther; Suárez Pinilla, Paula

; Ferrod, Adele; Tabarés Seisdedos, Rafael; Crespo Facorro, Benedicto

; Ayesa Arriola, Rosa

(Taylor & Francis, 2020)

Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia

Albacete, Auria; Contreras, Fernando; Bosque, Clara; Gilabert, Ester; Albiach, Ángela; Menchón, José M.; Crespo Facorro, Benedicto

; Ayesa Arriola, Rosa

(Frontiers Media, 2016)

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program

Pardo de Santayana Jenaro, Guillermo; Vázquez Bourgon, Javier

; Gómez Revuelta, Marcos; Ayesa Arriola, Rosa

; Ortiz Garcia de la Foz, Victor; Crespo Facorro, Benedicto

; Pelayo Terán, José María (Elsevier BV, 2020-04-23)

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis

Vázquez Bourgon, Javier

; Ortiz García de la Foz, Víctor; Suarez Pereira, Irene; Iruzubieta, Paula; Arias Loste, María Teresa

; Setién Suero, María Esther; Ayesa Arriola, Rosa

; Gómez Revuelta, Marcos; Crespo García, Javier

; Crespo Facorro, Benedicto

(Elsevier BV, 2019-12)

Diferencias neurocognitivas entre mujeres menores y mayores de 40 años que presentan un primer episodio de psicosis no afectivas

Velasco Solana, Susana (2021-09-01)

Does Childhood trauma impact on cognitive performance in adulthood? : A comparative study between patients with First Episode of Psychosis (FEP), their siblings and healthy control subjects

Sánchez Sierra, Laura (2020-06-29)

Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

Ruso Julve, Fulgencio; Pombero, Ana; Pilar Cuéllar, María Fuencisla

; García-Díaz, Nuria; García López, Raquel

; Juncal-Ruiz, María; Castro Fernández, María Elena

; Díaz Martínez, Álvaro

; Vázquez Bourgon, Javier

; García-Blanco, Agustín; Garro Martínez, Emilio; Pisonero, Helena; Estirado, Alicia; Ayesa Arriola, Rosa

; López-Giménez, Juan; Mayor Jr., Federico; Valdizán, Elsa; Meana, Javier; Gonzalez-Maeso, Javier; [et al.] (Nature Pub. Group, 2019)

Educación sanitaria en pacientes con nefrostomía: impacto económico y calidad de vida

Fernández Cacho, Luis Manuel

(2019-12-19)

Effects of copy number variations on brain structure and risk for psychiatric illness: large-scale studies from the ENIGMA working groups on CNVs

Sonderby, Ida E.; Ching, Chistopher R. K.; Thomopoulos, Sophia I.; Van der Meer, Dennis; Sun, Daqiang; Villalon-Reina, Julio E.; Agartz, Ingrid; Amunts, Katrin; Arango, Celso; Armstrong, Nicola J.; Ayesa Arriola, Rosa

; Bakker, Geor; Bassett, Anne S.; Boomsma, Dorret I.; Bülow, Robin; Butcher, Nancy J.; Calhoun, Vince D.; Tordesillas Gutiérrez, Diana

; Vázquez Bourgon, Javier

(Wiley-Liss Inc, 2022)

Estudio longitudinal sobre el consumo de cannabis en primeros episodios de psicosis

Setién Suero, Esther (2018-11-30)

Visualizar por autor "Ayesa Arriola, Rosa"

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis

A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype

Análisis de la velocidad de procesamiento en Primeros Episodios Psicóticos

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial

Biomarkers as proxies for cognitive reserve: the role of high density lipoprotein cholesterol in first episode of psychosis

Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences

Carga alostática en pacientes con un primer episodio psicótico: estudio longitudinal a 1, 3 y 10 años de seguimiento

Childhood early life adverse events and neurocognitive deficits in first episode psychosis patients

Childhood trauma and substance use underlying psychosis: a systematic review

Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis

Diferencias neurocognitivas entre mujeres menores y mayores de 40 años que presentan un primer episodio de psicosis no afectivas

Does Childhood trauma impact on cognitive performance in adulthood? : A comparative study between patients with First Episode of Psychosis (FEP), their siblings and healthy control subjects

Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

Educación sanitaria en pacientes con nefrostomía: impacto económico y calidad de vida

Effects of copy number variations on brain structure and risk for psychiatric illness: large-scale studies from the ENIGMA working groups on CNVs

Estudio longitudinal sobre el consumo de cannabis en primeros episodios de psicosis

Listar

Mi cuenta

Sobre UCrea

Piensa en abierto

Compartir

Visualizar por autor "Ayesa Arriola, Rosa"

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis ﻿

A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype ﻿

Análisis de la velocidad de procesamiento en Primeros Episodios Psicóticos ﻿

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone ﻿

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial ﻿

Biomarkers as proxies for cognitive reserve: the role of high density lipoprotein cholesterol in first episode of psychosis ﻿

Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients ﻿

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences ﻿

Carga alostática en pacientes con un primer episodio psicótico: estudio longitudinal a 1, 3 y 10 años de seguimiento ﻿

Childhood early life adverse events and neurocognitive deficits in first episode psychosis patients ﻿

Childhood trauma and substance use underlying psychosis: a systematic review ﻿

Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia ﻿

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program ﻿

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis ﻿

Diferencias neurocognitivas entre mujeres menores y mayores de 40 años que presentan un primer episodio de psicosis no afectivas ﻿

Does Childhood trauma impact on cognitive performance in adulthood? : A comparative study between patients with First Episode of Psychosis (FEP), their siblings and healthy control subjects ﻿

Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics ﻿

Educación sanitaria en pacientes con nefrostomía: impacto económico y calidad de vida ﻿

Effects of copy number variations on brain structure and risk for psychiatric illness: large-scale studies from the ENIGMA working groups on CNVs ﻿

Estudio longitudinal sobre el consumo de cannabis en primeros episodios de psicosis ﻿

A Disrupted-in-Schizophrenia 1 Gene Variant is Associated with Clinical Symptomatology in Patients with First-Episode Psychosis

A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype

Análisis de la velocidad de procesamiento en Primeros Episodios Psicóticos

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone

Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial

Biomarkers as proxies for cognitive reserve: the role of high density lipoprotein cholesterol in first episode of psychosis

Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients

Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences

Carga alostática en pacientes con un primer episodio psicótico: estudio longitudinal a 1, 3 y 10 años de seguimiento

Childhood early life adverse events and neurocognitive deficits in first episode psychosis patients

Childhood trauma and substance use underlying psychosis: a systematic review

Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia

Data regarding active psychosis and functional outcome, among other clinical variables, during early phases of the illness in first-episode psychosis in the PAFIP 10-year follow-up program

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis

Diferencias neurocognitivas entre mujeres menores y mayores de 40 años que presentan un primer episodio de psicosis no afectivas

Does Childhood trauma impact on cognitive performance in adulthood? : A comparative study between patients with First Episode of Psychosis (FEP), their siblings and healthy control subjects

Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

Educación sanitaria en pacientes con nefrostomía: impacto económico y calidad de vida

Effects of copy number variations on brain structure and risk for psychiatric illness: large-scale studies from the ENIGMA working groups on CNVs

Estudio longitudinal sobre el consumo de cannabis en primeros episodios de psicosis